Cargando…
Expression of Myomaker and Myomerger in myofibers causes muscle pathology
BACKGROUND: Skeletal muscle development and regeneration depend on cellular fusion of myogenic progenitors to generate multinucleated myofibers. These progenitors utilize two muscle-specific fusogens, Myomaker and Myomerger, which function by remodeling cell membranes to fuse to each other or to exi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150476/ https://www.ncbi.nlm.nih.gov/pubmed/37127758 http://dx.doi.org/10.1186/s13395-023-00317-z |
_version_ | 1785035366767525888 |
---|---|
author | Witcher, Phillip C. Sun, Chengyi Millay, Douglas P. |
author_facet | Witcher, Phillip C. Sun, Chengyi Millay, Douglas P. |
author_sort | Witcher, Phillip C. |
collection | PubMed |
description | BACKGROUND: Skeletal muscle development and regeneration depend on cellular fusion of myogenic progenitors to generate multinucleated myofibers. These progenitors utilize two muscle-specific fusogens, Myomaker and Myomerger, which function by remodeling cell membranes to fuse to each other or to existing myofibers. Myomaker and Myomerger expression is restricted to differentiating progenitor cells as they are not detected in adult myofibers. However, Myomaker remains expressed in myofibers from mice with muscular dystrophy. Ablation of Myomaker from dystrophic myofibers results in reduced membrane damage, leading to a model where persistent fusogen expression in myofibers, in contrast to myoblasts, is harmful. METHODS: Dox-inducible transgenic mice were developed to ectopically express Myomaker or Myomerger in the myofiber compartment of skeletal muscle. We quantified indices of myofiber membrane damage, such as serum creatine kinase and IgM(+) myofibers, and assessed general muscle histology, including central nucleation, myofiber size, and fibrosis. RESULTS: Myomaker or Myomerger expression in myofibers independently caused membrane damage at acute time points. This damage led to muscle pathology, manifesting with centrally nucleated myofibers and muscle atrophy. Dual expression of both Myomaker and Myomerger in myofibers exacerbated several aspects of muscle pathology compared to expression of either fusogen by itself. CONCLUSIONS: These data reveal that while myofibers can tolerate some level of Myomaker and Myomerger, expression of a single fusogen above a threshold or co-expression of both fusogens is damaging to myofibers. These results explain the paradigm that their expression in myofibers can have deleterious consequences in muscle pathologies and highlight the need for their highly restricted expression during myogenesis and fusion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13395-023-00317-z. |
format | Online Article Text |
id | pubmed-10150476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101504762023-05-02 Expression of Myomaker and Myomerger in myofibers causes muscle pathology Witcher, Phillip C. Sun, Chengyi Millay, Douglas P. Skelet Muscle Research BACKGROUND: Skeletal muscle development and regeneration depend on cellular fusion of myogenic progenitors to generate multinucleated myofibers. These progenitors utilize two muscle-specific fusogens, Myomaker and Myomerger, which function by remodeling cell membranes to fuse to each other or to existing myofibers. Myomaker and Myomerger expression is restricted to differentiating progenitor cells as they are not detected in adult myofibers. However, Myomaker remains expressed in myofibers from mice with muscular dystrophy. Ablation of Myomaker from dystrophic myofibers results in reduced membrane damage, leading to a model where persistent fusogen expression in myofibers, in contrast to myoblasts, is harmful. METHODS: Dox-inducible transgenic mice were developed to ectopically express Myomaker or Myomerger in the myofiber compartment of skeletal muscle. We quantified indices of myofiber membrane damage, such as serum creatine kinase and IgM(+) myofibers, and assessed general muscle histology, including central nucleation, myofiber size, and fibrosis. RESULTS: Myomaker or Myomerger expression in myofibers independently caused membrane damage at acute time points. This damage led to muscle pathology, manifesting with centrally nucleated myofibers and muscle atrophy. Dual expression of both Myomaker and Myomerger in myofibers exacerbated several aspects of muscle pathology compared to expression of either fusogen by itself. CONCLUSIONS: These data reveal that while myofibers can tolerate some level of Myomaker and Myomerger, expression of a single fusogen above a threshold or co-expression of both fusogens is damaging to myofibers. These results explain the paradigm that their expression in myofibers can have deleterious consequences in muscle pathologies and highlight the need for their highly restricted expression during myogenesis and fusion. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13395-023-00317-z. BioMed Central 2023-05-01 /pmc/articles/PMC10150476/ /pubmed/37127758 http://dx.doi.org/10.1186/s13395-023-00317-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Witcher, Phillip C. Sun, Chengyi Millay, Douglas P. Expression of Myomaker and Myomerger in myofibers causes muscle pathology |
title | Expression of Myomaker and Myomerger in myofibers causes muscle pathology |
title_full | Expression of Myomaker and Myomerger in myofibers causes muscle pathology |
title_fullStr | Expression of Myomaker and Myomerger in myofibers causes muscle pathology |
title_full_unstemmed | Expression of Myomaker and Myomerger in myofibers causes muscle pathology |
title_short | Expression of Myomaker and Myomerger in myofibers causes muscle pathology |
title_sort | expression of myomaker and myomerger in myofibers causes muscle pathology |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150476/ https://www.ncbi.nlm.nih.gov/pubmed/37127758 http://dx.doi.org/10.1186/s13395-023-00317-z |
work_keys_str_mv | AT witcherphillipc expressionofmyomakerandmyomergerinmyofiberscausesmusclepathology AT sunchengyi expressionofmyomakerandmyomergerinmyofiberscausesmusclepathology AT millaydouglasp expressionofmyomakerandmyomergerinmyofiberscausesmusclepathology |